top of page
DEVELOPMENT
DEVELOPMENT
TissueGen is advancing toward clinical development a pipeline of novel, extended release
TissueGen is advancing toward clinical development a pipeline of novel, extended release
formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.
formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.
A paradigm shift in drug delivery systems
TissueGen's proprietary technology makes possible extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics. Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.
ABOUT
biologics. Our patent-protected technology is particularly well suited to creating a new class
release formulations for drugs ranging from small molecules to temperature-sensitive
TissueGen's proprietary technology makes possible extended
of drug-eluting devices designed to orchestrate the body's own healing processes
to significantly improve clinical outcomes after trauma or surgery.
- Dr. Kevin Nelson, Founder and CSO
APPLICATIONS
ABOUT
APPLICATIONS
bottom of page